Starpharma has developed the DEP® (dendrimer enhanced product) drug delivery platform to enhance the delivery and effectiveness of pharmaceutical drugs. This technology has the potential to offer significant therapeutic and commercial opportunities for a wide range of drugs across various therapeutic areas.
